Adjuvant Transthoracic Negative-Pressure Ventilation in Nonintubated Thoracoscopic Surgery.
VATS
emphysema
interstitial lung disease
nonintubated thoracic surgery
spontaneous ventilation
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
23 Jun 2023
23 Jun 2023
Historique:
received:
22
05
2023
revised:
15
06
2023
accepted:
20
06
2023
medline:
14
7
2023
pubmed:
14
7
2023
entrez:
14
7
2023
Statut:
epublish
Résumé
To minimize the risks of barotrauma during nonintubated thoracoscopic-surgery under spontaneous ventilation, we investigated an adjuvant transthoracic negative-pressure ventilation (NPV) method in patients operated on due to severe emphysema or interstitial lung disease. In this retrospective study, NPV was employed for temporary low oxygen saturation and to achieve end-operative lung re-expansion during nonintubated lung volume reduction surgery (LVRS) for severe emphysema (30 patients, LVRS group) and in the nonintubated wedge resection of undetermined interstitial lung disease (30 patients, wedge-group). The results were compared following 1:1 propensity score matching with equivalent control groups undergoing the same procedures under spontaneous ventilation, with adjuvant positive-pressure ventilation (PPV) performed on-demand through the laryngeal mask. The primary outcomes were changes (preoperative-postoperative value) in the arterial oxygen tension/fraction of the inspired oxygen ratio (ΔPO Intergroup comparisons (NPV vs. PPV) showed no differences in demographic and pulmonary function. NPV could be accomplished in all instances with no conversion to general anesthesia with intubation. In the LVRS group, NPV improved ΔPO In this retrospective study, NITS with adjuvant transthoracic NPV resulted in better 24 h oxygenation measures than PPV in both the LVRS and wedge groups, and in better lung expansion according to the CXR score in the wedge group.
Sections du résumé
BACKGROUND
BACKGROUND
To minimize the risks of barotrauma during nonintubated thoracoscopic-surgery under spontaneous ventilation, we investigated an adjuvant transthoracic negative-pressure ventilation (NPV) method in patients operated on due to severe emphysema or interstitial lung disease.
METHODS
METHODS
In this retrospective study, NPV was employed for temporary low oxygen saturation and to achieve end-operative lung re-expansion during nonintubated lung volume reduction surgery (LVRS) for severe emphysema (30 patients, LVRS group) and in the nonintubated wedge resection of undetermined interstitial lung disease (30 patients, wedge-group). The results were compared following 1:1 propensity score matching with equivalent control groups undergoing the same procedures under spontaneous ventilation, with adjuvant positive-pressure ventilation (PPV) performed on-demand through the laryngeal mask. The primary outcomes were changes (preoperative-postoperative value) in the arterial oxygen tension/fraction of the inspired oxygen ratio (ΔPO
RESULTS
RESULTS
Intergroup comparisons (NPV vs. PPV) showed no differences in demographic and pulmonary function. NPV could be accomplished in all instances with no conversion to general anesthesia with intubation. In the LVRS group, NPV improved ΔPO
CONCLUSIONS
CONCLUSIONS
In this retrospective study, NITS with adjuvant transthoracic NPV resulted in better 24 h oxygenation measures than PPV in both the LVRS and wedge groups, and in better lung expansion according to the CXR score in the wedge group.
Identifiants
pubmed: 37445268
pii: jcm12134234
doi: 10.3390/jcm12134234
pmc: PMC10342242
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Am J Respir Crit Care Med. 2008 Feb 15;177(4):412-8
pubmed: 18079496
J Heart Lung Transplant. 2018 Apr;37(4):520-530
pubmed: 29103845
Lancet. 2017 Feb 18;389(10070):701-708
pubmed: 28108038
Eur J Cardiothorac Surg. 2021 Sep 11;60(3):598-606
pubmed: 33860323
J Clin Monit Comput. 2021 Aug;35(4):859-868
pubmed: 32535849
Interact Cardiovasc Thorac Surg. 2021 May 27;32(6):938-941
pubmed: 33569581
Am J Respir Crit Care Med. 2020 Apr 1;201(7):767-774
pubmed: 31665612
Respir Care. 2013 Mar;58(3):525-31
pubmed: 23443285
Eur J Cardiothorac Surg. 2012 Apr;41(4):831-3
pubmed: 22228846
Pediatrics. 1967 May;39(5):740-8
pubmed: 5229705
Respir Care. 2019 Jun;64(6):629-637
pubmed: 31110032
J Vis Surg. 2016 Mar 23;2:61
pubmed: 29078489
Chest. 2008 May;133(5):1113-9
pubmed: 17989156
Ann Transl Med. 2017 Jul;5(14):290
pubmed: 28828365
J Appl Physiol (1985). 2017 Jun 1;122(6):1516-1522
pubmed: 28385915
Biomed Res Int. 2015;2015:746560
pubmed: 26783527
Am J Respir Crit Care Med. 2019 Jul 15;200(2):140-151
pubmed: 31022350
Medicine (Baltimore). 2019 Apr;98(17):e15389
pubmed: 31027133
Ann Transl Med. 2019 Feb;7(3):40
pubmed: 30906744
Expert Rev Respir Med. 2018 May;12(5):403-414
pubmed: 29575957
Am J Respir Crit Care Med. 2001 Jun;163(7):1614-8
pubmed: 11401883
Chest. 2002 Jul;122(1):99-107
pubmed: 12114344
Ann Thorac Surg. 2013 Feb;95(2):445-52
pubmed: 23245450
Crit Care Med. 2004 Sep;32(9):1817-24
pubmed: 15343007
Eur Respir J. 1997 Jul;10(7):1663-74
pubmed: 9230263
J Thorac Cardiovasc Surg. 2012 Jan;143(1):47-54, 54.e1
pubmed: 22056369
Interact Cardiovasc Thorac Surg. 2019 May 1;28(5):744-750
pubmed: 30508104
Respir Care. 2013 Jun;58(6):938-49
pubmed: 23709193
Eur J Cardiothorac Surg. 2020 Mar 1;57(3):428-437
pubmed: 31725158
Eur Respir J. 2002 Jul;20(1):187-97
pubmed: 12166569